Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Cramer's 'Mad Money' Recap: Panicking Brokers

Stock quotes in this article: AAPL, T, ED, CLH, UNP, COST, OPK, WMT, COP, CVX, JNJ, PEP, HD, CAB, BWP, VVUS, JCP, SHLD, FTR, RHT, HPQ, PNRA, ATW, SNE, BMY, CAT, XOM, SIRI, BMR, KIM, MCD 

Cramer would be a buyer of the oil and gas names into weakness, however, as he sees no reason for them to fall further. He likes ConocoPhillips (COP) and Chevron (CVX). Cramer was also bullish on the banks, those that are actually making money, as well as the HMOs, but not any hospital stocks.

Cramer also recommended owning gold, as well as packaged goods makers that sell overseas like Johnson & Johnson (JNJ) or Pepsico (PEP).

Finally, Cramer said he likes Home Depot (HD) as it helps the Northeast rebuild from the hurricane, as well as Cabellas (CAB), which has gotten cheap going into the cold, winter season.

Lightning Round

In the Lightning Round, Cramer was bullish on Boardwalk Partners (BWP).

Cramer was bearish on Vivus (VVUS), JC Penney (JCP), Sears Holdings (SHLD) and Frontier Communications (FTR).

In the Pipeline

In his second "Executive Decision" segment, Cramer spoke with Dr. Phillip Frost, chairman and CEO of Opko Health (OPK), a speculative biotech company with no less than six exciting new products under development.

Frost talked about his company's efforts in the Vitamin D market, which is a $2.5 billion market in the U.S. He said that Opko's new Vitamin D test can be done in the doctor's office, avoiding the need to send a sample to a lab for analysis, which saves both time and money.

Frost also talked about Opko's new prostate cancer screening, called a 4K Score. He said that with a simple drop of blood, the 4K test provides patients with a number determining the likelihood that they have prostate cancer and how aggressive that cancer might be. He said the test can eliminate the need for millions of needless biopsies preformed every year. The test is already on the market in the U.K. and could reach the U.S. by early 2013.

Cramer said Opko remains one of his favorite long-term biotech stories.

Am I Diversified?

In the "Am I Diversified?" segment, Cramer spoke with callers and responded to tweets sent via Twitter to @JimCramer to see if investors' portfolios have what it takes for today's markets.

The first portfolio included: RedHat (RHT), Hewlett-Packard (HPQ), Panera Bread (PNRA), Atwood Oceanics (ATW) and Sony (SNE).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%
US 10 Yr 2.026% +0.082

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs